Arena Pharmaceuticals Stock News

Technically speaking, the major U.S. benchmarks are off to a constructive July start despite persistently uneven price action, writes Michael Ashbaugh.

HighTower Advisors LLC purchased a new position in shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchan

AQR Capital Management LLC decreased its holdings in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 32.4% in the first quarter, according to the company in its most recent filing with the Securities and

Skandinaviska Enskilda Banken AB publ lessened its position in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 19.8% during the 1st quarter, according to the company in its most recent Form 13F filing wi

Technically speaking, the major U.S. benchmarks are poised to conclude June against an increasingly uneven, but still generally bullish, bigger-picture...

Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) have received a consensus recommendation of “Buy” from the fourteen analysts that are covering the company, MarketBeat Ratings reports. Two anal

These companies are all surprising doubters lately.

Geode Capital Management LLC raised its stake in shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 6.6% in the first quarter, according to the company in its most recent disclosure with the SEC.

Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish, on balance, despite increasingly uneven market price action, writes...

Stocks Analysis by Harry Boxer covering: Bed Bath & Beyond Inc, Ballard Power Systems Inc, Apache Corporation, Arena Pharmaceuticals Inc. Read Harry Boxer's latest article on Investing.com

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on June 15, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase an aggregate of 80,2

Massachusetts Financial Services Co. MA increased its stake in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 18.8% during the 1st quarter, according to the company in its most recent Form 13F filing wi

Deutsche Bank AG lifted its position in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 26.9% during the first quarter, Holdings Channel reports. The institutional investor owned 272,052 shares of the bi

Nuveen Asset Management LLC increased its stake in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 48.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the appointment of Dr. Katharine Knobil to the Company's Board of Directors. Dr. Knobil brings more than 20 years of leadership and expertise